Introduction

Trust. Support. As a family we advance.
R&D

Creation through
Challenges for the Future

Research for new drug started at Yangji Chemical, a subsidiary of Han Wha, in 1987.

In order to support the research program, YANIKEM s.a.r.l was founded in France, cultivating researchers with global competence and Han Wha has established collaborative research system with academic institute to enhance the efficiency of research & development.

In 2007, R&D center moved into Gyeonggi Bio Center and since then the research has been carried out in an excellent surroundings.
Our researches are in pursuit of new drug, incrementally modified drug, specialized generics, and new functional food ingredient.

Research programs

Cardiovascular Disorders

Endocrine Diseases

Respiratory Diseases

Digestion Diseases

Obstetrics & Gynecology Diseases

Musculoskeletal and Pain Disorders

Sustained Release

Multi-Layer Tablet

Extrusion &
Spheronization

Granulation

Pellet Coating

M-LAC Tech

MUL-CRAB Tech

Pipelines

Incrementally Modified Drugs Development

Project Research Formulation Pre-Clinical Phase I Phase II Phase III NDA / Launch
YJF-008
(Respiratory System Disorders)
YJQ-101
(GI Tract System Disorders)
HWI-001
(Musculo-Skeletal Disorders/Peripheral Artery Diseases)
HWI-002
(Musculo-Skeletal Disorders)
HWO-001
(Cardiovascular Diseases + Endocrine Disorders)
HWO-002
(Endocrine Disorders)

Differentiation 1st Generic Drugs Developments

Project Research Formulation Phase I NDA / Launch
YJF-009
(Respiratory System Disorders)
YJF-015
(Fever Reducer & Pain Reliever)
YJF-019
(Respiratory System Disorders)

Health Functional Food Materials Developments

Project Research Pre-Clinical Human Study Certi / Launch
NLH-001
(Antioxidant/Whitening)
NLH-002
(Antioxidant/Immune)

Pipelines

Incrementally Modified Drugs Development

* You can scroll left and right to see

NDA / Launch
PhaseIII
PhaseII
PhaseI
Pre-Clincial
Formulation
Research
Project YJF-008
(Respiratory System Disorders)
YJQ-101
(GI Tract System Disorders)
HWI-001
(Musculo-Skeletal Disorders/Peripheral Artery Diseases)
HWI-002
(Musculo-Skeletal Disorders)
HWO-001
(Cardiovascular Diseases + Endocrine Disorders)
HWO-002
(Endocrine Disorders)

Differentiation 1st Generic Drugs Developments

* You can scroll left and right to see

NDA / Launch
Phase I
Formulation
Research
Project YJF-009
(Respiratory System Disorders)
YJF-015
(Fever Reducer & Pain Reliever)
YJF-019
(Respiratory System Disorders)

Health Functional Food Materials Developments

Certi / Launch
Human Study
Pre-Clinical
Research
Project NLH-001
(Antioxidant/Whitening)
NLH-002
(Antioxidant/Immune)